GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Institutional Ownership

Revive Therapeutics (XCNQ:RVV) Institutional Ownership : 0.55% (As of Jun. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Revive Therapeutics's institutional ownership is 0.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Revive Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Revive Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


Revive Therapeutics Institutional Ownership Historical Data

The historical data trend for Revive Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Institutional Ownership Chart

Revive Therapeutics Historical Data

The historical data trend for Revive Therapeutics can be seen below:

2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31
Institutional Ownership 1.55 1.69 1.70 1.81 2.27 2.25 1.58 1.58 1.01 0.55

Revive Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Revive Therapeutics (XCNQ:RVV) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
Executives
Michael Frank Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines